Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Unintended consequences of regulatory initiatives in childhood cancer drug development.

× No keyword cloud information.

7 in total

1. Completion Rate and Reporting of Mandatory Pediatric Postmarketing Studies Under the US Pediatric Research Equity Act.

Authors: Thomas J Hwang; Liat Orenstein; Aaron S Kesselheim; Florence T Bourgeois
Journal: JAMA Pediatr Date: 2019-01-01 Impact factor: 16.193

Review 2. Improving the outcome for children with cancer: Development of targeted new agents.

Authors: Peter C Adamson
Journal: CA Cancer J Clin Date: 2015-03-09 Impact factor: 508.702

3. New regulatory paradigms for innovative drugs to treat pediatric diseases.

Authors: Thomas J Hwang; Florence T Bourgeois
Journal: JAMA Pediatr Date: 2014-10 Impact factor: 16.193

Review 4. Drug discovery in paediatric oncology: roadblocks to progress.

Authors: Peter C Adamson; Peter J Houghton; Giorgio Perilongo; Kathy Pritchard-Jones
Journal: Nat Rev Clin Oncol Date: 2014-09-16 Impact factor: 66.675

Review 5. A New Ethical Challenge for Institutional Review Boards (IRBs)/Ethics Committees (ECs) in the Assessment of Pediatric Clinical Trials.

Authors: Klaus Rose; Hans Kummer
Journal: Children (Basel) Date: 2015-05-28

6. Use of Modeling and Simulation in the Design and Conduct of Pediatric Clinical Trials and the Optimization of Individualized Dosing Regimens.

Authors: C Stockmann; J S Barrett; J K Roberts; Cmt Sherwin
Journal: CPT Pharmacometrics Syst Pharmacol Date: 2015-11-13

Review 7. The contributions of the European Medicines Agency and its pediatric committee to the fight against childhood leukemia.

Authors: Klaus Rose; Philip D Walson
Journal: Risk Manag Healthc Policy Date: 2015-11-05

7 in total